Claire L Keating, MD
Overview
Claire Keating, MD is the Associate Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program since 2009.
Areas of Expertise / Conditions Treated
- Asthma
- Bronchiectasis
- Cystic Fibrosis
- General Pulmonology
- Lung Disease
- Primary Ciliary Dyskinesia
- Pulmonary Disease
- Pulmonary Medicine
Academic Appointments
- Associate Professor of Medicine at CUMC
Administrative Titles
- Associate Director, Gunnar Esiason Adult Cystic Fibrosis and Lung Center
- Co-Director, Therapeutics Development Network, Cystic Fibrosis Foundation
- Assistant Director, Bronchiectasis Center
- Co-Director, Primary Ciliary Dyskinesia Center (provisional)
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
Affinity Health Plan
Amida Care
Cigna
Emblem/GHI
Emblem/HIP
Empire Blue Cross/Blue Shield
Empire Blue Cross Blue Shield HealthPlus
Fidelis Care
Healthfirst
Local 1199
MagnaCare (National)
Medicare
Multiplan
MVP Health Care
RiverSpring
UnitedHealthcare
VNSNY CHOICE
WellCare
World Trade Center Health Plan
Credentials & Experience
Education & Training
- BS, 1997 Biological Sciences: Genetics and Development, Cornell University, Ithaca, NY
- MD, 2003 Tufts University of Medicine
- Internship: 2004 NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Residency: 2006 NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Fellowship: 2009 NewYork-Presbyterian Hospital/Columbia University Medical Center
Board Certifications
- Internal Medicine
- Pulmonary Disease Medicine
Honors & Awards
- 2019-Present: Irving Institute Clinical Research Resource Scientific Advisory Committee Member
- 2019-Present: Cystic Fibrosis Foundation; Greater New York Chapter Medical Board of Directors Member
- 2019-Present: Cystic Fibrosis Foundation; Therapeutic Development Network Protocol Review Committee Member
- 2012-Present: Cystic Fibrosis Foundation; Therapeutic Development Network Publications and Presentations Committee Member
- 2019-2021: Therapeutic Development Network Principal Investigator Protected Effort (PIPE) Award
- 2015-2016: Cystic Fibrosis Foundation OneCF Learning and Leadership Collaborative 2, Quality Improvement Award, Team Leader
- 2013: Cystic Fibrosis Foundation Adult Quality Improvement 3, Learning and Leadership Collaborative Quality Improvement Award, Team Champion
- 2006: Weill Cornell Medical Center Daniel M. Libby Program Director’s Award for Clinical Excellence
- 2001: Tufts University Medical Center Presidential Award for Citizenship and Public Service
- 1997: Golden Key National Honor Society, Cornell University
Research
Research Interests
- Cystic Fibrosis Therapeutics and Patient Outcomes
- Non-cystic Fibrosis Bronchiectasis
- Non-tuberculous Mycobacterial Disease
Selected Publications
Djavid AR, Thompson AE, Irace AL, Gusman E, Altman K, DiMango EA, Keating CL. Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease. Ann Am Thorac Soc. 2021 May 17
DiMango E, Overdevest J, Keating C, Francis SF, Dansky D, Gudis D. Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis. J Cyst Fibros. 2021 May;20(3):460-463.
Lucas G Axiotakis Jr; Necati Enver; Claire L Keating; Michael J Pitman. Laryngeal Injury due to Amikacin Inhalation for Refractory MAC Infection. Chest. 2021 Apr;159(4):e185-e187
DiMango E, Overdevest J, Keating C, Francis SF, Dansky D, Gudis D. Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis Int Forum Allergy Rhinol. 2021 Jan;11(1):75-78.
Claire L Keating, Jonathan B Zuckerman, Pradeep K Singh, Matthew McKevitt, Oksana Gurtovaya, Mark Bresnik, Bruce C Marshall, Lisa Saiman. Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e02327-20.
Chetan Safi, Zhong Zheng, Emily Dimango, Claire Keating, David A. Gudis. Chronic Rhinosinusitis in Cystic Fibrosis: Diagnosis and Medical Management. Med. Sci. 2019, 7, 32.
Nishiyama KK, Agarwal S, Kepley A, Rosete F, Hu Y, Guo XE, Keating CL, DiMango EA, Shane E. Adults with cystic fibrosis have deficits in bone structure and strength at the distal tibia despite similar size and measuring standard and relative sites. Bone. 2018 Feb;107:181-187
Keating, C, Poor A, Liu X, Chiuzan, C, Backenroth D, Zhang, Y, Dimango E. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. Journal of Cystic Fibrosis. 2017 Jan;16(1):78-84
Dimango E, Walker P, Keating C, Berdella M, Robinson N, Langfelder-Schwind E, et al. Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulm Med. 2014 Feb 15;14:21.
Keating CL, Liu X, Dimango EA Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest. 2010 May;137(5):1157-63.
For a complete list of publications, please visit PubMed.gov(link is external and opens in a new window)